High Purity>99% Peptide Ss-31 Selank Mt2 Dsip Epithalon Adipotide Hi-Q Betty
52 Inquiries
307297-39-8
ep
99%
HongKong
10vials
2026-11-09
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceEpitalon is an anti-aging agent and a telomerase activator. Epitalon has an inhibitory effect of the on the development of spontaneous tumors in mice, has geroprotective actions and intranasal administration increases neuronal activity. Epitalon can be used for cancer, old age and Retinitis Pigmentosa[1].Basic Info
-
Product Name:
Epitalon
Other Name:AE-0 peptide;Ala-Glu-Asp-Gly;alanyl-glutamyl-aspartyl-glycine;epitalon;epithalon;epithalone;307297-39-8;UNII-O65P17785G
CAS No.:307297-39-8
Molecular Formula:C14H22N4O9
InChIKeys:HGHOBRRUMWJWCU-FXQIFTODSA-N
Molecular Weight:390.346
Exact Mass:390.138672
Categories:
Characteristics-
PSA:
225
XLogP3:-2.02
Density:1.5±0.1 g/cm3
Boiling Point:959.8±65.0 °C at 760 mmHg
Flash Point:534.3±34.3 °C
Refractive Index:1.559
Research-
Class:
Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)
Status:FDA-approved (Forzinity) — Accelerated Approval 2025
Mechanism:A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.
Activity note:SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.
Source:Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI
Clinical Development:FDA:Forzinity (approved 2025-09-19)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
FDA: Forzinity (NDA 215244) — Accelerated Approval 2025; Genetics in Medicine: TAZPOWER Phase 2/3 results (Thompson et al. 2020); Drugs: Elamipretide First Approval (Springer 2025)
Disclaimer:Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Location:
1502A1, Building 4, Xinyuanxin Center, No. 3 Huaxin Road, Dongfeng Street, Licheng District, Jinan City, Shandong Province
-
Payment Terms:
TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
Certifications:
COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA
-
-
Inquiry History52 Inquiries
Country Product Purchase Quantity Date Posted 
United States
N-Acetyl Epitalon Amidate CAS 307297-39-8 Epitalon 99% White Powder 99% N-Acetyl Epitalon Amidate
1 Oct 4, 2023
United States
N-Acetyl Epitalon Amidate CAS 307297-39-8 Epitalon 99% White Powder 99% N-Acetyl Epitalon Amidate
1 G Oct 7, 2023
United States
Epitalon, NAD+, DSIP, 5-Amino-1MQ, PEG-MGF
1 May 9, 2026
United States
epithalon
10 MG Jun 3, 2026
United States
Epitalon
10 MT May 14, 2026 
United Kingdom
Epitalon
50 MT Apr 22, 2026 
Australia
Epithalon
2 G Apr 3, 2026
United States
Epithalon
500 MG Mar 25, 2026
Australia
Epithalon
30 MG Mar 19, 2026
United Kingdom
Epitalon
200 MG Mar 18, 2026
United States
Epitalon
50 MT Mar 16, 2026
United States
Epitalon
1 PCS Mar 10, 2026 
India
Epitalon
1 KG Feb 26, 2026
United States
Epitalon (CAS 307297-39-8) and Pinealon (CAS 175175-23-2) - ORAL CAPSULE Form Only
1000 PCS Feb 4, 2026
United States
Epitalon & Pinealon Peptides - Oral Capsule Form
10 G Feb 3, 2026
United States
Epithalon
10 Jan 6, 2026
United States
Epitalon
2 G Jan 6, 2026
United States
Epitalon
5 MT Jul 19, 2025
United States
Epithalon
10 MT Apr 2, 2025 
South Korea
epitalon
1 G Feb 22, 2025 Post an enquiry for this product
